BRIEF published on 07/01/2026 at 07:35, 23 days 12 hours ago Nicox: NDA submitted for NCX 470 in the United States FDA Glaucoma Nicox NCX 470 Kowa
BRIEF published on 06/23/2026 at 07:35, 1 month 1 day ago Nicox and Vester Finance: Partnership to Support Strategic Initiatives Funding New Actions Nicox NCX 470 Vester Finance
BRIEF published on 06/23/2026 at 07:35, 1 month 1 day ago Nicox and Vester Finance Enter Strategic Shareholder Loan Agreement Strategic Flexibility Nicox Shareholder Loan NCX 470 Vester Finance
PRESS RELEASE published on 06/23/2026 at 07:30, 1 month 1 day ago Nicox and Vester Finance Sign Shareholder Loan Agreement to Support Strategic Activities for the Company Nicox and Vester Finance sign a €6.0 million shareholder loan agreement to support strategic activities, providing flexibility for future opportunities Financial Agreement Nicox Shareholder Loan Vester Finance Strategic Activities
BRIEF published on 06/18/2026 at 07:35, 1 month 6 days ago Nicox Receives Positive Feedback for NCX 470 in China Ophthalmology Nicox NCX 470 Regulatory Feedback NDA China
PRESS RELEASE published on 06/18/2026 at 07:30, 1 month 6 days ago Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470 Nicox's licensee in China, Ocumension, receives positive regulatory feedback for NCX 470, advancing towards NDA filing. Global milestones set for NCX 470 submissions Nicox NCX 470 Ocumension NDA Filing Regulatory Feedback
BRIEF published on 06/08/2026 at 07:35, 1 month 16 days ago Nicox warrants expiring soon in June 2024 Euronext Stock Trading Ophthalmology Nicox BSA Expiration
BRIEF published on 06/08/2026 at 07:35, 1 month 16 days ago Nicox Reminds Investors of June 2024 Warrants Expiration Warrants Stock Market Nicox Expiration Sophia Antipolis
PRESS RELEASE published on 06/08/2026 at 07:30, 1 month 16 days ago Reminder: Nicox June 2024 Warrants will expire June 19, 2026 Nicox reminds holders of June 2024 warrants expiring on June 19, 2026. Exercise details provided. Contact financial intermediary for exercise. Company information available at www.nicox.com Warrants Exercise Nicox Expiration Financial Intermediary
BRIEF published on 06/03/2026 at 07:35, 1 month 21 days ago Nicox Announces Shareholders’ Meeting and Appointment of Ad Hoc Representative Voting Rights Shareholders’ Meeting Quorum Nicox Ad Hoc Representative
Published on 07/24/2026 at 14:00, 5 hours 44 minutes ago NanoViricides Announces Pricing of ~$3.8 Million Registered Direct Offering
Published on 07/24/2026 at 13:10, 6 hours 34 minutes ago Spirit Blockchain Capital Appoints Suha Askary as Chief Executive Officer
Published on 07/24/2026 at 09:10, 10 hours 34 minutes ago HM Exploration Commences Optical & Acoustic Televiewer Program at the Lewis Pilley's Project
Published on 07/24/2026 at 08:00, 11 hours 44 minutes ago Galantas Announces Amendment to a Dragones Share Purchase Agreement
Published on 07/24/2026 at 05:55, 13 hours 49 minutes ago Alphinat Announces a Loss of $(44,521) for Quarter Ended May 31, 2026
Published on 07/24/2026 at 17:50, 1 hour 54 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/24/2026 at 17:40, 2 hours 4 minutes ago 2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of May 31, 2026.
Published on 07/24/2026 at 18:50, 54 minutes ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 08:00, 11 hours 44 minutes ago Accor signs a definitive binding agreement on the sale of its stake in Essendi
